Protara Therapeutics Inc (TARA)
EBITDA Growth
-45.31%
Quarterly · Period ending:
TARA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-45.31%period ending
Latest reported-45.31%period ending
TARA Quarterly EBITDA YoY % (-3892.54% → -45.31%)
Year-over-year change
High-resolution chart · PNG
TARA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -45.3102% | |
| -49.5393% | |
| -35.6822% | |
| -18.2757% | |
| -57.6034% | |
| -7.4373% | |
| -25.44% | |
| -13.8432% | |
| 15.9237% | |
| -22.7921% | |
| -1.9762% | |
| -33.0205% | |
| -37.7887% | |
| 12.839% | |
| -20.0872% | |
| 23.3663% | |
| 33.4097% | |
| 21.7626% | |
| 7.1223% | |
| -19.4151% | |
| -68.5657% | |
| -30.0791% | |
| -445.871% | |
| 149.1869% | |
| 100% | |
| 100% | |
| 100% | |
| 5.2736% | |
| 63.42% | |
| 12.942% | |
| 6.3332% | |
| 20.3292% | |
| -73.487% | |
| 29.068% | |
| 5.294% | |
| -11.3505% | |
| -39.1578% | |
| -57.6792% | |
| -47.5974% | |
| -185.7576% | |
| -3,892.5373% |